Browse the corpus

Immediate "Kangaroo Mother Care" and Survival of Infants with Low Birth Weight. BACKGROUND: "Kangaroo mother care," a type of newborn care involving skin-to-skin contact with the mother or other caregiver, reduces mortality in infants with low birth weight (<2.0 kg) when initiated after stabilization, but the majority of deaths occur before stabilization. The safety and efficacy of kangaroo mother care initiated soon after birth among infants with low birth weight are uncertain. METHODS: We conducted a randomized, controlled trial in five hospitals in Ghana, India, Malawi, Nigeria, and Tanzania involving infants with a birth weight between 1.0 and 1.799 kg who were assigned to receive immediate kangaroo mother care (intervention) or conventional care in an incubator or a radiant warmer until their condition stabilized and kangaroo mother care thereafter (control). The primary outcomes were death in the neonatal period (the first 28 days of life) and in the first 72 hours of life. RESULTS: A total of 3211 infants and their mothers were randomly assigned to the intervention group (1609 infants with their mothers) or the control group (1602 infants with their mothers). The median daily duration of skin-to-skin contact in the neonatal intensive care unit was 16.9 hours (interquartile range, 13.0 to 19.7) in the intervention group and 1.5 hours (interquartile range, 0.3 to 3.3) in the control group. Neonatal death occurred in the first 28 days in 191 infants in the intervention group (12.0%) and in 249 infants in the control group (15.7%) (relative risk of death, 0.75; 95% confidence interval [CI], 0.64 to 0.89; P = 0.001); neonatal death in the first 72 hours of life occurred in 74 infants in the intervention group (4.6%) and in 92 infants in the control group (5.8%) (relative risk of death, 0.77; 95% CI, 0.58 to 1.04; P = 0.09). The trial was stopped early on the recommendation of the data and safety monitoring board owing to the finding of reduced mortality among infants receiving immediate kangaroo mother care. CONCLUSIONS: Among infants with a birth weight between 1.0 and 1.799 kg, those who received immediate kangaroo mother care had lower mortality at 28 days than those who received conventional care with kangaroo mother care initiated after stabilization; the between-group difference favoring immediate kangaroo mother care at 72 hours was not significant. (Funded by the Bill and Melinda Gates Foundation; Australian New Zealand Clinical Trials Registry number, ACTRN12618001880235; Clinical Trials Registry-India number, CTRI/2018/08/015369.).

Low birth weight (LBW) infants, born preterm and/or small for gestational age, constitute about 15% of neonates, but account for 70% of all neonatal deaths. Reducing deaths in LBW infants, particularly in low- and middle- income countries (LMICs) in Asia and Sub-Saharan Africa, is therefore key to the achievement of the Sustainable Development Goal target of reducing neonatal mortality to <12/1000 live births in each country by 2030.1–3

ount for 70% of all neonatal deaths. Reducing deaths in LBW infants, particularly in low- and middle- income countries (LMICs) in Asia and Sub-Saharan Africa, is therefore key to the achievement of the Sustainable Development Goal target of reducing neonatal mortality to <12/1000 live births in each country by 2030.1–3 Kangaroo Mother Care, defined as continuous skin-to-skin contact of the baby with the mother’s chest and exclusive breastmilk feeding, is one of the most effective interventions for preventing mortality of LBW infants.4 World Health Organization (WHO) 5 guidelines currently recommend initiation of short intermittent Kangaroo Mother Care sessions when the infant’s condition begins to stabilize, and continuous Kangaroo Mother Care when fully stable. A Cochrane review reported a 40% reduction in mortality in LBW infants given Kangaroo Mother Care after stabilization compared to conventional care in hospitals (3.2% versus 5.3%; risk ratio (RR) 0.60, 95% confidence interval (CI) 0.39 to 0.92; eight trials, 1736 infants).6 This review also showed fewer infections, higher exclusive breastfeeding and better weight gain in infants who received Kangaroo Mother Care. In studies included in the review, the mean age at randomization (when infants were considered stable) ranged from 10 hours to 24.5 days of life. About 45% of neonatal deaths occur within 24 hours of birth and 80% within the first week of life; 7 thus the majority of deaths among LBW infants occur before Kangaroo Mother Care can be initiated.

he review, the mean age at randomization (when infants were considered stable) ranged from 10 hours to 24.5 days of life. About 45% of neonatal deaths occur within 24 hours of birth and 80% within the first week of life; 7 thus the majority of deaths among LBW infants occur before Kangaroo Mother Care can be initiated. Two randomized controlled trials (RCTs) have evaluated the effect of initiating Kangaroo Mother Care immediately after birth on physiological stabilization. In South Africa 8 and Vietnam9, skin-to-skin contact started soon after birth in LBW infants resulted in earlier stabilization than conventional care. There is a critical knowledge gap regarding the effect of initiating continuous Kangaroo Mother Care soon after birth before stabilization on mortality in LBW infants. We conducted this large RCT to evaluate the safety and efficacy of continuous Kangaroo Mother Care initiated immediately after birth in infants with a birthweight of 1.0 to <1.8 kg.

The details of the study methods have been published previously and are briefly summarized here.10 This multi-center, non-blinded RCT was undertaken in five tertiary-level hospitals in Ghana, India, Malawi, Nigeria and Tanzania. All liveborn infants in the participating hospitals, with birthweight between 1.0 to <1.8kg regardless of their gestational age, mode of delivery or singleton/twin status, were eligible for inclusion. Mother-infant(s) pairs were excluded if the mother was <15 years old, unable or unwilling to provide consent, had triplets or more, was sick and unlikely to be able to provide Kangaroo Mother Care within the first 3 days after birth, could not be enrolled within 2 hours of childbirth or resided outside the study area. Infants who were unable to breathe spontaneously by one hour of age or had a major congenital malformation were also excluded. This trial was approved by Ethics Review Committees at WHO and at each site. The study was overseen by a steering committee and a Data and Safety Monitoring Board (DSMB). RB, SR, SY and NM vouch for the accuracy and completeness of the data and for the fidelity of the trial to the protocol. Three independent teams, trained in study standard operating procedures, were responsible for (1) screening and enrolment (2) Kangaroo Mother Care support and (3) outcome measurement at each site.

This trial was approved by Ethics Review Committees at WHO and at each site. The study was overseen by a steering committee and a Data and Safety Monitoring Board (DSMB). RB, SR, SY and NM vouch for the accuracy and completeness of the data and for the fidelity of the trial to the protocol. Three independent teams, trained in study standard operating procedures, were responsible for (1) screening and enrolment (2) Kangaroo Mother Care support and (3) outcome measurement at each site. Pre-screening of all pregnant women admitted for childbirth was conducted to identify women at high risk of delivering a LBW infant and consent for study participation was sought. All infants born in the hospital were weighed and screened for eligibility. If the mother and infant were eligible, consent was confirmed if it had already been obtained before birth. If consent could not be obtained before birth, it was obtained after birth. At enrolment, mothers were asked to identify one or two adult women who could act as their surrogates for providing Kangaroo Mother Care; only women are permitted to stay in postnatal areas in all study hospitals.

dy been obtained before birth. If consent could not be obtained before birth, it was obtained after birth. At enrolment, mothers were asked to identify one or two adult women who could act as their surrogates for providing Kangaroo Mother Care; only women are permitted to stay in postnatal areas in all study hospitals. Randomization was performed using a computer-generated block list, with variable block size, stratified by site and birthweight 1.0 to <1.5kg and 1.5 to <1.8kg. The random allocation was sealed in serially numbered, opaque envelopes prepared at the WHO and delivered to the sites. A research assistant conducted randomization by opening the next numbered envelope. Twins were allocated to the same group. The nature of the intervention prevented blinding, but outcome assessment was done by an independent team not involved in intervention delivery. System changes in obstetric and neonatal care as well as structural changes to the neonatal intensive care unit (NICU) were necessary. Mother-NICU, which included mothers’ beds and reclining chairs, were built or converted from an existing NICU. All equipment, staff and care provision in the Mother-NICU remained the same as the NICU. The infant was secured firmly to the mother’s chest with a binder that ensured a patent airway.11 All care to the mother and infant were provided while in skin-to-skin contact if possible, all interruptions were documented. Obstetricians supervised essential postpartum care provided to mothers in the Mother-NICU.

NICU. The infant was secured firmly to the mother’s chest with a binder that ensured a patent airway.11 All care to the mother and infant were provided while in skin-to-skin contact if possible, all interruptions were documented. Obstetricians supervised essential postpartum care provided to mothers in the Mother-NICU. Infants allocated to control group were transferred to the NICU without the mother, following the standard care practices. The mother provided expressed breast milk, and brief sessions of Kangaroo Mother Care when the infant started to recover and was at least 24 hours old. Hospital staff provided care for all enrolled infants according to the WHO minimum care package for small infants.12 In both intervention and control groups, once clinically stable based on pre-specified criteria10 for 24 hours, the infant was shifted from Mother-NICU or NICU to Kangaroo Mother Care ward where continuous Kangaroo Mother Care was provided until discharge.

according to the WHO minimum care package for small infants.12 In both intervention and control groups, once clinically stable based on pre-specified criteria10 for 24 hours, the infant was shifted from Mother-NICU or NICU to Kangaroo Mother Care ward where continuous Kangaroo Mother Care was provided until discharge. The primary outcomes were mortality from enrolment to 28 days of age and mortality from enrolment to 72 hours of age. Secondary outcomes included hypothermia (any axillary temperature < 36°C), hypoglycemia (any blood glucose level < 45 mg/dl, measured when clinically indicated), suspected sepsis, time to clinical stabilization, fully breastfed (only by suckling) at the time of discharge, exclusive breastfeeding at the end of neonatal period, maternal satisfaction with care and maternal depression (supplementary Table S1).10 Additionally, mortality from birth to 72 hours in non-enrolled infants 1.0 to <1.8 kg was documented. The only serious adverse event assessed according to the protocol was death. Outcome data were collected using identical methods and procedures for all enrolled infants. Clinical monitoring was done every 6 hours for all infants while they were in Mother-NICU or NICU. Information on duration of skin-to-skin contact and duration of hospital stay was collected by research assistants. A home visit was performed on day 29 for data on survival, breastfeeding and maternal depression.

nfants. Clinical monitoring was done every 6 hours for all infants while they were in Mother-NICU or NICU. Information on duration of skin-to-skin contact and duration of hospital stay was collected by research assistants. A home visit was performed on day 29 for data on survival, breastfeeding and maternal depression. We estimated that 4200 infants were needed to detect a 20% relative mortality reduction at 28 days (16.8% mortality in intervention group compared with 21.1% in control group), with 95% confidence level and 90% power and 10% loss to follow-up. The DSMB conducted interim analyses at 50% and 75% enrolment. After the second interim analysis, the DSMB recommended stopping enrolment in the trial because of a clear benefit in neonatal survival. (See supplementary appendix.) Intention-to-treat analyses were performed for primary and secondary outcomes.10 Risk ratios and 95% CI were calculated for the outcomes. Adjusted risk ratios were estimated using log-binomial regression controlled for clustering due to multiple births and other important baseline characteristics which could be potential confounders. Hazard ratios were calculated using multivariable Cox survival analysis to compare time to clinical stabilization between groups. We used marginal mean imputation for missing values in continuous covariates and the most frequent response to impute categorical variables. No imputation was made for the primary outcomes.

Hazard ratios were calculated using multivariable Cox survival analysis to compare time to clinical stabilization between groups. We used marginal mean imputation for missing values in continuous covariates and the most frequent response to impute categorical variables. No imputation was made for the primary outcomes. Pre-specified subgroup analyses were performed to explore modification of effect of immediate Kangaroo Mother Care on primary outcomes by birthweight (1.0 to <1.2kg, 1.2 to <1.5 kg, 1.5 to <1.8 kg), gestational age (<31, 31 to <34, 34 to <37, ≥37 weeks), mode of delivery (vaginal birth, Caesarean section), singleton/twin gestation, and size for gestational age (small for gestational age, not small for gestational age).10 Subgroup analyses by site was conducted post-hoc. In the intervention group, we examined the primary outcomes in subgroups by compliance to Kangaroo Mother Care (skin-to-skin contact for ≥20 hours, 10–19 hours, and <10 hours per day). To address reverse causality in this analysis, we excluded infants with any sign of severe illness in the first 6 hours of life. Causes of death were assigned by investigators based on clinical information for hospital deaths and by verbal autopsy for deaths at home after discharge.

10–19 hours, and <10 hours per day). To address reverse causality in this analysis, we excluded infants with any sign of severe illness in the first 6 hours of life. Causes of death were assigned by investigators based on clinical information for hospital deaths and by verbal autopsy for deaths at home after discharge. Post hoc analyses were conducted to explore the effect of the intervention on breastfeeding during hospital stay, including proportion of newborns by group who had initiated breastmilk feeds within 24 hours, were put to breast in the first 72 hours, reached full breastmilk feeds within 7 days, and were discharged on exclusive breastmilk feeding.

This multi-center, non-blinded RCT was undertaken in five tertiary-level hospitals in Ghana, India, Malawi, Nigeria and Tanzania. All liveborn infants in the participating hospitals, with birthweight between 1.0 to <1.8kg regardless of their gestational age, mode of delivery or singleton/twin status, were eligible for inclusion. Mother-infant(s) pairs were excluded if the mother was <15 years old, unable or unwilling to provide consent, had triplets or more, was sick and unlikely to be able to provide Kangaroo Mother Care within the first 3 days after birth, could not be enrolled within 2 hours of childbirth or resided outside the study area. Infants who were unable to breathe spontaneously by one hour of age or had a major congenital malformation were also excluded. This trial was approved by Ethics Review Committees at WHO and at each site. The study was overseen by a steering committee and a Data and Safety Monitoring Board (DSMB). RB, SR, SY and NM vouch for the accuracy and completeness of the data and for the fidelity of the trial to the protocol.

Three independent teams, trained in study standard operating procedures, were responsible for (1) screening and enrolment (2) Kangaroo Mother Care support and (3) outcome measurement at each site. Pre-screening of all pregnant women admitted for childbirth was conducted to identify women at high risk of delivering a LBW infant and consent for study participation was sought. All infants born in the hospital were weighed and screened for eligibility. If the mother and infant were eligible, consent was confirmed if it had already been obtained before birth. If consent could not be obtained before birth, it was obtained after birth. At enrolment, mothers were asked to identify one or two adult women who could act as their surrogates for providing Kangaroo Mother Care; only women are permitted to stay in postnatal areas in all study hospitals. Randomization was performed using a computer-generated block list, with variable block size, stratified by site and birthweight 1.0 to <1.5kg and 1.5 to <1.8kg. The random allocation was sealed in serially numbered, opaque envelopes prepared at the WHO and delivered to the sites. A research assistant conducted randomization by opening the next numbered envelope. Twins were allocated to the same group. The nature of the intervention prevented blinding, but outcome assessment was done by an independent team not involved in intervention delivery.

pes prepared at the WHO and delivered to the sites. A research assistant conducted randomization by opening the next numbered envelope. Twins were allocated to the same group. The nature of the intervention prevented blinding, but outcome assessment was done by an independent team not involved in intervention delivery. System changes in obstetric and neonatal care as well as structural changes to the neonatal intensive care unit (NICU) were necessary. Mother-NICU, which included mothers’ beds and reclining chairs, were built or converted from an existing NICU. All equipment, staff and care provision in the Mother-NICU remained the same as the NICU. The infant was secured firmly to the mother’s chest with a binder that ensured a patent airway.11 All care to the mother and infant were provided while in skin-to-skin contact if possible, all interruptions were documented. Obstetricians supervised essential postpartum care provided to mothers in the Mother-NICU. Infants allocated to control group were transferred to the NICU without the mother, following the standard care practices. The mother provided expressed breast milk, and brief sessions of Kangaroo Mother Care when the infant started to recover and was at least 24 hours old.

System changes in obstetric and neonatal care as well as structural changes to the neonatal intensive care unit (NICU) were necessary. Mother-NICU, which included mothers’ beds and reclining chairs, were built or converted from an existing NICU. All equipment, staff and care provision in the Mother-NICU remained the same as the NICU. The infant was secured firmly to the mother’s chest with a binder that ensured a patent airway.11 All care to the mother and infant were provided while in skin-to-skin contact if possible, all interruptions were documented. Obstetricians supervised essential postpartum care provided to mothers in the Mother-NICU. Infants allocated to control group were transferred to the NICU without the mother, following the standard care practices. The mother provided expressed breast milk, and brief sessions of Kangaroo Mother Care when the infant started to recover and was at least 24 hours old. Hospital staff provided care for all enrolled infants according to the WHO minimum care package for small infants.12 In both intervention and control groups, once clinically stable based on pre-specified criteria10 for 24 hours, the infant was shifted from Mother-NICU or NICU to Kangaroo Mother Care ward where continuous Kangaroo Mother Care was provided until discharge.

The primary outcomes were mortality from enrolment to 28 days of age and mortality from enrolment to 72 hours of age. Secondary outcomes included hypothermia (any axillary temperature < 36°C), hypoglycemia (any blood glucose level < 45 mg/dl, measured when clinically indicated), suspected sepsis, time to clinical stabilization, fully breastfed (only by suckling) at the time of discharge, exclusive breastfeeding at the end of neonatal period, maternal satisfaction with care and maternal depression (supplementary Table S1).10 Additionally, mortality from birth to 72 hours in non-enrolled infants 1.0 to <1.8 kg was documented. The only serious adverse event assessed according to the protocol was death. Outcome data were collected using identical methods and procedures for all enrolled infants. Clinical monitoring was done every 6 hours for all infants while they were in Mother-NICU or NICU. Information on duration of skin-to-skin contact and duration of hospital stay was collected by research assistants. A home visit was performed on day 29 for data on survival, breastfeeding and maternal depression.

We estimated that 4200 infants were needed to detect a 20% relative mortality reduction at 28 days (16.8% mortality in intervention group compared with 21.1% in control group), with 95% confidence level and 90% power and 10% loss to follow-up. The DSMB conducted interim analyses at 50% and 75% enrolment. After the second interim analysis, the DSMB recommended stopping enrolment in the trial because of a clear benefit in neonatal survival. (See supplementary appendix.) Intention-to-treat analyses were performed for primary and secondary outcomes.10 Risk ratios and 95% CI were calculated for the outcomes. Adjusted risk ratios were estimated using log-binomial regression controlled for clustering due to multiple births and other important baseline characteristics which could be potential confounders. Hazard ratios were calculated using multivariable Cox survival analysis to compare time to clinical stabilization between groups. We used marginal mean imputation for missing values in continuous covariates and the most frequent response to impute categorical variables. No imputation was made for the primary outcomes.

A total of 87,381 pregnant women were pre-screened and 79,850 infants were screened for eligibility between 30 November 2017 and 20 January 2020, of which 5357 infants (from 4859 mothers) met the weight criteria for enrolment. Of them, 3211 infants (2944 mothers) were randomly allocated - 1609 infants (1470 mothers) to the intervention group and 1602 infants (1474 mothers) to the control group (Figure 1). Table 1 and Table S2 show the baseline characteristics of randomized infants, their mothers and their families. Socio-demographic, newborn and maternal characteristics were similar in both groups. The mean gestation was 32.6 weeks and mean birthweight was 1.5 kg in both groups. Only 0.3% randomized infants had missing observations for covariates, except family income which was missing for 8%. The median age of initiation of skin-to-skin contact was 1.3 hours (IQR 0.8–2.7) in intervention group, and 53.6 hours (IQR 33.8 – 101.4) in control group. The duration of NICU stay was similar in intervention and control groups (median 6.4 days in both groups). During NICU stay, median daily duration of skin-to-skin contact was 16.9 hours (and 1.5 hours, respectively. The daily duration on each day in the first two weeks is given in Table S3. The main reasons for not being in skin-to-skin contact in the intervention group were medical procedures, infant care and routine activities of mother. The median daily duration of skin-to-skin contact in the Kangaroo Mother Care ward was similar in both groups (20.2 hours vs 19.0 hours) (Table 2).

s given in Table S3. The main reasons for not being in skin-to-skin contact in the intervention group were medical procedures, infant care and routine activities of mother. The median daily duration of skin-to-skin contact in the Kangaroo Mother Care ward was similar in both groups (20.2 hours vs 19.0 hours) (Table 2). From enrolment to 28 days of age, 191 infants (12.0%) in the intervention group and 249 (15.7%) in the control group died (RR 0.75, 95% CI 0.64–0.89; p=0.001). The number needed to treat was 27 (95% CI 17–77) to prevent one death. From enrolment to 72 hours of age, 74 infants (4.6%) in intervention and 92 infants (5.8%) in control group died (RR 0.77, 95% CI 0.58–1.04; p=0.09) (Table 3). The intervention had similar effects across birthweights, gestation and weight for gestational age categories, different modes of delivery, and singletons or twins. (Figure 2 and Figure S1). All sites showed benefit in their point estimates except Ghana. In the intervention group, the risk of death was lower in infants who received more hours of skin-to-skin contact per day (Table S4). Most deaths were caused by sepsis and preterm birth complications. Sepsis-associated mortality was 4.4% in the intervention group and 6.9% in the control group (RR 0.64, 95% CI 0.48 to 0.86). (Table S5).

on group, the risk of death was lower in infants who received more hours of skin-to-skin contact per day (Table S4). Most deaths were caused by sepsis and preterm birth complications. Sepsis-associated mortality was 4.4% in the intervention group and 6.9% in the control group (RR 0.64, 95% CI 0.48 to 0.86). (Table S5). Secondary outcome results are presented in Table 3. The proportion of infants with suspected sepsis was 22.9% in intervention group and 27.8% in control group (adjusted RR 0.82, 95% CI 0.73–0.93); hypothermia was documented in 5.6% and 8.3%, respectively (adjusted RR 0.65, 95%CI 0.51–0.83). The time to stabilization and incidences of hypoglycemia, feeding fully by suckling at the time of discharge, and exclusive breastfeeding at the end of neonatal period were similar in both groups. In post-hoc analyses, breastmilk feeding was initiated within the first 24 hours in 58.5% vs 45.5% of infants, and full breastmilk feeding within 7 days was achieved in 78.4% vs 69.0%, respectively (Table S6). Of 2146 infants with birthweight between 1.0 and <1.8 kg who were not enrolled in the trial, 340 (15.8%) died by 72 hours.

This multicenter trial demonstrated that initiation of continuous Kangaroo Mother Care soon after birth for infants with birthweight between 1.0 to <1.8 kg improved neonatal survival by 25%, compared with Kangaroo Mother Care initiated after stabilization, as is currently recommended. The intervention would need to be provided to 27 infants (95% CI 17–77) to prevent one neonatal death. Implementation of the intervention required the mother, or a surrogate, to be with the baby all the time which required establishment of Mother-NICUs. The lower observed rates of hypothermia and suspected sepsis, though not adjusted for multiplicity, are consistent with results for the primary outcome and may at least in part explain the mortality benefits of immediate Kangaroo Mother Care.

o be with the baby all the time which required establishment of Mother-NICUs. The lower observed rates of hypothermia and suspected sepsis, though not adjusted for multiplicity, are consistent with results for the primary outcome and may at least in part explain the mortality benefits of immediate Kangaroo Mother Care. Findings for the primary outcome and for infection and hypothermia were similar to those reported in earlier trials of the use of Kangaroo Mother Care in clinically stable infants.6 However, we did not find differences between the intervention and control groups in the two pre-specified feeding outcomes—being fully breastfed by suckling at discharge and exclusive breastfeeding at the end of the neonatal period, despite post-hoc analyses suggesting higher rates of initiation of breast-milk feeding within 24 hours, putting the baby to the breast within 72 hours and reaching full breast-milk feeding within 7 days of birth in the intervention group. We also did not find a material difference between groups in the time to stabilization, unlike two previous RCTs of a similar intervention. 8,9 As compared to the studies that achieved intermittent Kangaroo Mother Care in the Cochrane review 6, we achieved high compliance with the intervention, i.e., about 17 hours of skin-to-skin contact per day.

al difference between groups in the time to stabilization, unlike two previous RCTs of a similar intervention. 8,9 As compared to the studies that achieved intermittent Kangaroo Mother Care in the Cochrane review 6, we achieved high compliance with the intervention, i.e., about 17 hours of skin-to-skin contact per day. There are several possible mechanisms by which immediate Kangaroo Mother Care might confer benefit. As the mother and baby are in close contact from birth, the baby is more likely to be colonized by the mother’s protective microbiome, more likely to receive early breastmilk feeding and there is less handling of the baby, thus reducing the risk of infection.13–19 Constant monitoring of the infant by the mother, more frequent glucose monitoring, and decreased stress20 of mother-infant separation could also contribute to reduced mortality. Further studies in well-resourced settings could help to determine to what extent these enhanced survival results from LMIC settings are relevant to low-mortality settings with intensive infant monitoring. We observed that the risk of death was lower in infants who received more hours of skin-to-skin contact per day. However, this association is subject to confounding by medical issues in the infant that may have precluded prolonged skin-to-skin contact.

elevant to low-mortality settings with intensive infant monitoring. We observed that the risk of death was lower in infants who received more hours of skin-to-skin contact per day. However, this association is subject to confounding by medical issues in the infant that may have precluded prolonged skin-to-skin contact. The results of this study are generalizable to most hospitals in low-resource settings where immediate-Kangaroo Mother Care can be implemented as described here. Challenges in scaling up of this intervention would include multiple stakeholders’ involvement, establishment of Mother-NICUs, a strong collaboration between obstetric and neonatal departments, and policy changes allowing surrogates to provide Kangaroo Mother Care.

aroo Mother Care can be implemented as described here. Challenges in scaling up of this intervention would include multiple stakeholders’ involvement, establishment of Mother-NICUs, a strong collaboration between obstetric and neonatal departments, and policy changes allowing surrogates to provide Kangaroo Mother Care. Some limitations merit discussion. The nature of the intervention made blinding impossible. However, ensuring allocation concealment until completion of enrolment, rigorous adherence to predefined protocol and choice of mortality as a primary outcome minimize measurement bias. The open label design may have resulted in measurement bias in some of the secondary outcomes, which were more subjective, but would not affect our primary mortality outcomes. There was heterogeneity in the infrastructure, staff, practices and possible differences in patient profile across sites; however, this should increase the generalizability of our findings. It is not possible to partition the beneficial effect of the intervention between immediate initiation of Kangaroo Mother Care and simply the presence of the mother with her baby, because both are integral part of the intervention. Finally, approximately 20% of infants 1.0 to <1.8 kg born in study hospitals were not enrolled because mother or newborn was too sick for this intervention, which needs to be considered in estimating the potential public health impact of the intervention.

th her baby, because both are integral part of the intervention. Finally, approximately 20% of infants 1.0 to <1.8 kg born in study hospitals were not enrolled because mother or newborn was too sick for this intervention, which needs to be considered in estimating the potential public health impact of the intervention. In summary, in this large, multi-site, multi-country study, conducted in low resource hospitals, continuous Kangaroo Mother Care initiated immediately after birth in infants with a birthweight of 1.0 to <1.8 kg resulted in a significantly lower risk of neonatal death, although not of death within 72 hours, compared to the current WHO recommendation of initiating Kangaroo Mother Care after stabilization.